Aligos Therapeuticsinc Stock Investor Sentiment
| ALGS Stock | USD 0.82 0.02 2.50% |
Slightly above 55% of Aligos TherapeuticsInc's private investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Aligos TherapeuticsInc suggests that some traders are interested. Aligos TherapeuticsInc's investor sentiment overview provides quick insight into current market opportunities from investing in Aligos TherapeuticsInc. The current market sentiment, together with Aligos TherapeuticsInc's historical and current headlines, can help investors time the market. In addition, many technical investors use Aligos TherapeuticsInc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Aligos TherapeuticsInc stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Aligos daily returns and investor perception about the current price of Aligos TherapeuticsInc as well as its diversification or hedging effects on your existing portfolios.
Aligos |
Aligos TherapeuticsInc Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Aligos TherapeuticsInc can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Aligos TherapeuticsInc that are available to investors today. That information is available publicly through Aligos media outlets and privately through word of mouth or via Aligos internal channels. However, regardless of the origin, that massive amount of Aligos data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Aligos TherapeuticsInc news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Aligos TherapeuticsInc relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Aligos TherapeuticsInc's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Aligos TherapeuticsInc alpha.
Aligos TherapeuticsInc Performance against NYSE Composite
Price Growth (%) |
| Timeline |
1 | Aligos Therapeutics, Inc. Short Interest Up 6.4 percent in January - AmericanBankingNEWS | 02/16/2024 |
2 | Aligos Therapeutics, Inc.s Share Price Is Matching Sentiment Around Its Revenues | 02/23/2024 |
3 | Disposition of 30000 shares by Martell Bridget A of Aligos TherapeuticsInc at 16.52 subject to Rule 16b-3 | 02/27/2024 |
4 | Acquisition by Martell Bridget A of 8823 shares of Aligos TherapeuticsInc at 0.96 subject to Rule 16b-3 | 02/28/2024 |
5 | Acquisition by Blatt Lawrence of 965435 shares of Aligos TherapeuticsInc at 1.13 subject to Rule 16b-3 | 03/01/2024 |
6 | Acquisition by Mcclure Matthew W. of 72000 shares of Aligos TherapeuticsInc at 1.13 subject to Rule 16b-3 | 03/04/2024 |
7 | Aligos Therapeutics on the Brink The Urgent Race to Maintain Nasdaq Listing and Avoid Delisting Consequences ... - TipRanks | 03/13/2024 |
8 | Aligos Therapeutics, Inc. Just Flashed Golden Cross Signal Do You Buy | 03/27/2024 |
9 | Aligos Therapeutics, Inc. Stock Catapults 27 percent Though Its Price And Business Still Lag The Industry | 04/09/2024 |
10 | Acquisition by Leonid Beigelman of 169500 shares of Aligos TherapeuticsInc at 1.34 subject to Rule 16b-3 | 04/12/2024 |
11 | Vanguard Group Inc. Increases Stock Position in Aligos Therapeutics, Inc. - Defense World | 04/16/2024 |
Check out Aligos TherapeuticsInc Hype Analysis, Aligos TherapeuticsInc Correlation and Aligos TherapeuticsInc Performance. For more information on how to buy Aligos Stock please use our How to Invest in Aligos TherapeuticsInc guide.Note that the Aligos TherapeuticsInc information on this page should be used as a complementary analysis to other Aligos TherapeuticsInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Complementary Tools for Aligos Stock analysis
When running Aligos TherapeuticsInc's price analysis, check to measure Aligos TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aligos TherapeuticsInc is operating at the current time. Most of Aligos TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Aligos TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aligos TherapeuticsInc's price. Additionally, you may evaluate how the addition of Aligos TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |
Is Aligos TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aligos TherapeuticsInc. If investors know Aligos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aligos TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.36) | Revenue Per Share 0.242 | Quarterly Revenue Growth (0.24) | Return On Assets (0.37) | Return On Equity (0.89) |
The market value of Aligos TherapeuticsInc is measured differently than its book value, which is the value of Aligos that is recorded on the company's balance sheet. Investors also form their own opinion of Aligos TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Aligos TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aligos TherapeuticsInc's market value can be influenced by many factors that don't directly affect Aligos TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aligos TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aligos TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aligos TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.